IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
TUESDAY, Oct. 17, 2023 (HealthDay News) — Two doses of a novel intranasal live-attenuated COVID-19 vaccine, CoviLiv, induce poly-antigenic immune response, according to a study presented at the annual meeting of the Infectious Diseases Society of Ame…
Learn MoreMás de 7 millones de estadounidenses han recibido las nuevas vacunas contra COVID-19
LUNES, 16 de octubre de 2023 (HealthDay News) — Después de un lanzamiento problemático, ahora más de 7 millones de estadounidenses han recibido las nuevas vacunas actualizadas contra la COVID-19.Desafortunadamente, esto todavía está rezagado en compa…
Learn MoreMore Than 7 Million Americans Have Gotten the New COVID-19 Vaccines
FRIDAY, Oct. 13, 2023 (HealthDay News) — Following a rocky rollout, more than 7 million Americans have now gotten the newly updated COVID-19 vaccines. Unfortunately, that is still lagging behind the number who sought booster shots last fall. For the …
Learn MoreMore Than 7 Million Americans Have Gotten the New COVID Shots
FRIDAY, Oct. 13, 2023 (HealthDay News) — Following a rocky rollout, more than 7 million Americans have now gotten the newly updated COVID vaccines.Unfortunately, that’s still lagging behind the number who sought booster shots last fall. For the the f…
Learn MoreLa vacuna contra COVID en aerosol nasal arroja resultados prometedores en la fase inicial de un estudio
JUEVES, 12 de octubre de 2023 (HealthDay News) — Una nueva investigación señala el potencial de una vacuna contra COVID-19 administrada por la nariz.El ensayo clínico de fase 1 mostró que el producto, administrado nasalmente en dos dosis, produjo una…
Learn More¿Quieres reducir tus probabilidades de tener COVID prolongado? Duerme más
MIÉRCOLES, 11 de octubre de 2023 (HealthDay News) – Una forma de ayudar a reducir las probabilidades de tener COVID prolongado en personas con condiciones preexistentes podría ser dormir más.Un nuevo estudio descubrió que el riesgo era menor en aquell…
Learn MoreNasal Spray COVID Vaccine Shows Promise in Early Trial
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — New research points to the potential of a COVID-19 vaccine delivered through the nose.The phase 1 clinical trial showed that the product, administered nasally in two doses, delivered a significant immune re…
Learn MoreAutoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19
TUESDAY, Oct. 10, 2023 (HealthDay News) — COVID-19 is associated with an increased risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Oct. 6 in JAMA Network Open.Sung Ha Lim, M.D., from the Yon…
Learn MoreCOVID Might Raise Odds for Immune Disorders Like Crohn’s, Alopecia
TUESDAY, Oct. 10, 2023 (HealthDay News) — In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis, vitiligo (white skin patches), vasculit…
Learn More